Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Continuous glucose monitoring system
|
| gptkbp:alerts |
On-body vibration
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:dataRate |
Smartphone app
|
| gptkbp:headquartersLocation |
gptkb:Germantown,_Maryland,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eversense
|
| gptkbp:launched |
2016
|
| gptkbp:manufacturer |
gptkb:Senseonics
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:measures |
Interstitial glucose levels
|
| gptkbp:premise |
Eversense E3 is the latest model
Eversense XL is a European model |
| gptkbp:requires |
Professional sensor insertion
Professional sensor removal |
| gptkbp:sensorType |
up to 180 days
Implantable glucose sensor |
| gptkbp:transceiverType |
Wearable transmitter
|
| gptkbp:usedFor |
Diabetes management
|
| gptkbp:bfsParent |
gptkb:Senseonics
|
| gptkbp:bfsLayer |
6
|